Staining solution for cataract surgeries available as vial and syringe
Industry updates


Colin Kerr
Published: Sunday, January 1, 2017
[caption id="attachment_6216" align="alignnone" width="750"]
Vioron staining solution[/caption]
STAINING SOLUTION
Vioron is Geuder’s number one tissue staining solution for cataract surgeries, and is available as vial and syringe.“It consists of trypan blue and ensures an effective staining and thus brilliant visualisation of the anterior lens capsule,” said a company spokesman.
“This staining solution enables an excellent distinction of the capsulorhexis margin. It is quick and easy to apply, and applicable to a variety of further indications, e.g. congenital or (hyper) mature cataract surgery,” added the spokesman.
www.geuder.com
EXPANDED CUSTOMER REACH
HOYA has announced a definitive agreement to acquire Performance Optics, including its subsidiaries VISION EASE and Daemyung Optical. Performance Optics is a global ophthalmic lens manufacturer specialising in polycarbonate, photochromic, polarised and high-index eyeglass lenses.
“The acquisition of Performance Optics expands HOYA’s customer reach, particularly through VISION EASE’s presence in the Americas and its strengths in polycarbonate products and technologies,” said Girts Cimermans, CEO of HOYA Vision Care. “Performance Optics provides HOYA with additional capabilities,” he added.
www.hoya.com
NEW APPOINTMENT
Carl Zeiss Meditec has appointed Steven C Schallhorn MD as Chief Medical Officer for Global Ophthalmic Devices, consisting of refractive lasers, surgical ophthalmology and ophthalmic diagnostics.
Dr Schallhorn will serve on the Executive Leadership Team, providing strategic direction for the business and medical guidance on the clinical use of ZEISS’ portfolio of ophthalmic diagnostic and surgical technologies. The company said Dr Schallhorn will collaborate with key opinion leaders.

Tags: industry, new products, product updates
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.